Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
ARPC1B binds WASP to control actin polymerization and curtail tonic signaling in B cells
Gabriella Leung, Yuhuan Zhou, Philip Ostrowski, Sivakami Mylvaganam, Parastoo Boroumand, Daniel J. Mulder, Conghui Guo, Aleixo M. Muise, Spencer A. Freeman
Gabriella Leung, Yuhuan Zhou, Philip Ostrowski, Sivakami Mylvaganam, Parastoo Boroumand, Daniel J. Mulder, Conghui Guo, Aleixo M. Muise, Spencer A. Freeman
View: Text | PDF
Research Article Cell biology Immunology

ARPC1B binds WASP to control actin polymerization and curtail tonic signaling in B cells

  • Text
  • PDF
Abstract

Immune cells exhibit low-level, constitutive signaling at rest (tonic signaling). Such tonic signals are required for fundamental processes, including the survival of B lymphocytes, but when they are elevated by genetic or environmental causes, they can lead to autoimmunity. Events that control ongoing signal transduction are, therefore, tightly regulated by submembrane cytoskeletal polymers like F-actin. The actin-binding proteins that underpin the process, however, are poorly described. By investigating patients with ARPC1B deficiency, we report that ARPC1B-containing ARP2/3 complexes are stimulated by Wiskott Aldrich Syndrome protein (WASP) to nucleate the branched actin networks that control tonic signaling from the B cell receptor (BCR). Despite an upregulation of ARPC1A, ARPC1B-deficient cells were not capable of WASP-mediated nucleation by ARP2/3, and this caused the loss of WASP-dependent structures, including podosomes in macrophages and lamellipodia in B cells. In the B cell compartment, ARPC1B deficiency also led to weakening of the cortical F-actin cytoskeleton that normally curtails the diffusion of BCRs and ultimately resulted in increased tonic lipid signaling, oscillatory calcium release from the endoplasmic reticulum (ER), and phosphorylated Akt. These events contributed to skewing the threshold for B cell activation in response to microbial-associated molecular patterns (MAMPs). Thus, ARPC1B is critical for ARP2/3 complexes to control steady-state signaling of immune cells.

Authors

Gabriella Leung, Yuhuan Zhou, Philip Ostrowski, Sivakami Mylvaganam, Parastoo Boroumand, Daniel J. Mulder, Conghui Guo, Aleixo M. Muise, Spencer A. Freeman

×

Figure 3

ARPC1B-containing ARP2/3 complexes in the cortex constrain the lateral diffusion and merging or splitting of the BCR.

Options: View larger image (or click on image) Download as PowerPoint
ARPC1B-containing ARP2/3 complexes in the cortex constrain the lateral d...
(A) LCLs fixed and stained for F-actin and ARPC1B in suspension. The cortical F-actin intensity was determined for control and patient cell lines by measuring the mean fluorescence for 3–5 regions of the cortex for > 30 cells; n = 3. Data are represented as the mean ± SEM. (B) Primary splenic B cells treated with CK-689 (control) or CK-666 for 1 hour were incubated in cytoskeleton stabilization buffer and fractionated to determine the cytoskeletal-associated proteins (pellet, P) from those in the cytosol (solution, S). (C) Primary splenic B cells were fixed and stained in suspension. Scale bars: 10 μm. The cortical F-actin intensity (right) was determined as in A. Data are represented as the mean ± SEM. (D–I) Individual BCRs within the plasma membrane were tracked over 10- to 20-second periods at 10 Hz in cells immobilized on anti–MHC-II–coated surfaces. (D) In primary B cells from ARPC1B family 2, median diffusion coefficients for IgM-BCRs was measured from > 25 cells and > 2500 trajectories. (E and F) The median diffusion coefficient of IgG-BCRs was calculated from control or patient LCLs and those treated with CK-666 or CK-689. (G and H) Representative trajectories of IgG-BCR in control and patient 1 LCLs color-coded using an MSS analysis for motion types. Confined tracks (blue), free tracks (cyan), linear tracks (red), and unclassified tracks (black) are shown from 1 representative cell (G) and quantified (H) for > 20 cells, > 5000 BCR trajectories; n = 3. Data were analyzed using Mann Whitney U tests. Scale bar: 1 μm. (I) Merging and splitting analysis of IgM-BCRs in primary B cells derived from the same experiments described in D. *P < 0.05; **P < 0.01; ***P < 0.001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts